Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Legend Biotech Insider Sold Shares Worth $258,920, According to a Recent SEC Filing

Legend Biotech Insider Sold Shares Worth $258,920, According to a Recent SEC Filing

MT newswireMT newswire2026/10/01 20:09
04:09 PM EDT, 10/01/2026 (MT Newswires) -- Corazon (Corsee) D. Sanders, Director, on September 29, 2026, sold 27,370 shares in Legend Biotech (LEGN) for $258,920. Following the Form 4 filing with the SEC, Sanders has control over a total of 52,731 ordinary shares of the company, with 52,731 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1801198/000179653626000010/xslF345X05/form4-10012026_081003.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.

智通财经•2026/11/15 04:01
From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

UNI falls below $5

金色财经•2026/11/15 03:37
UNI falls below $5